BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37186844)

  • 21. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report.
    Yu L; Li J; Xu S; Navia Miranda M; Wang G; Duan Y
    Diagn Pathol; 2016 Oct; 11(1):98. PubMed ID: 27733182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.
    Msaouel P; Hong AL; Mullen EA; Atkins MB; Walker CL; Lee CH; Carden MA; Genovese G; Linehan WM; Rao P; Merino MJ; Grodman H; Dome JS; Fernandez CV; Geller JI; Apolo AB; Daw NC; Hodges HC; Moxey-Mims M; Wei D; Bottaro DP; Staehler M; Karam JA; Rathmell WK; Tannir NM
    Clin Genitourin Cancer; 2019 Feb; 17(1):1-6. PubMed ID: 30287223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal Medullary Carcinoma and Sickle Cell Trait: A Push for Early Diagnosis and Intervention Report of Two Cases.
    Carter SA; Walker AN
    J Natl Med Assoc; 2017 Spring; 109(1):63-65. PubMed ID: 28259220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal cell carcinoma with rhabdoid features and loss of INI1 expression in an individual without sickle cell trait.
    Scarpelli M; Mazzucchelli R; Lopez-Beltran A; Cheng L; De Nictolis M; Santoni M; Montironi R
    Pathology; 2014 Dec; 46(7):653-5. PubMed ID: 25393261
    [No Abstract]   [Full Text] [Related]  

  • 25. ALK rearrangement in sickle cell trait-associated renal medullary carcinoma.
    Mariño-Enríquez A; Ou WB; Weldon CB; Fletcher JA; Pérez-Atayde AR
    Genes Chromosomes Cancer; 2011 Mar; 50(3):146-53. PubMed ID: 21213368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal medullary carcinoma in a white adolescent with sickle cell trait.
    Daher P; Bourgi A; Riachy E; Khoury A; Rehayem C; Sader-Ghorra C
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):e285-9. PubMed ID: 24517963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approach for reclassification of collecting duct carcinoma and comparative histopathological analysis with SMARCB1/INI1-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma.
    Kiyozawa D; Kohashi K; Takamatsu D; Iwasaki T; Shibata D; Tomonaga T; Tateishi Y; Eto M; Kinjo M; Nishiyama K; Taguchi K; Oshiro Y; Kuboyama Y; Furuya M; Oda Y
    Hum Pathol; 2022 Jun; 124():36-44. PubMed ID: 35306021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case Report: Unclassified Renal Cell Carcinoma With Medullary Phenotype and
    Valeri M; Cieri M; Elefante GM; De Carlo C; Rudini N; Lughezzani G; Buffi NM; Terracciano LM; Colombo P
    Front Med (Lausanne); 2022; 9():835599. PubMed ID: 35198580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal medullary carcinoma: molecular, immunohistochemistry, and morphologic correlation.
    Liu Q; Galli S; Srinivasan R; Linehan WM; Tsokos M; Merino MJ
    Am J Surg Pathol; 2013 Mar; 37(3):368-74. PubMed ID: 23348212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of a renal medullary carcinoma in an adolescent male with sickle cell trait by Tc-99m methylene disphosponate bone scintigraphy.
    Brown JM; Berkey BD; Brooks JA
    Clin Nucl Med; 2008 Dec; 33(12):896-900. PubMed ID: 19033803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes.
    Gatalica Z; Lilleberg SL; Monzon FA; Koul MS; Bridge JA; Knezetic J; Legendre B; Sharma P; McCue PA
    Hum Pathol; 2011 Dec; 42(12):1979-88. PubMed ID: 21733559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinoma.
    Elwood H; Chaux A; Schultz L; Illei PB; Baydar DE; Billis A; Sharma R; Argani P; Epstein JI; Netto GJ
    Urology; 2011 Aug; 78(2):474.e1-5. PubMed ID: 21705046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic challenges of renal medullary carcinoma and the role for cytologic assessment: Case report and literature review.
    Severseike BO; Schafernak KT; Willard SD; Goncalves LF; Kothari AK; Eshun FK; Mangum R
    J Clin Lab Anal; 2023 Apr; 37(4):e24854. PubMed ID: 36843202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal medullary carcinoma and its association with sickle cell trait: a case report and literature review.
    Holland P; Merrimen J; Pringle C; Wood LA
    Curr Oncol; 2020 Feb; 27(1):e53-e56. PubMed ID: 32218668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma.
    Tourigny DS; Zucker M; Kim M; Russo P; Coleman J; Lee CH; Carlo MI; Chen YB; Hakimi AA; Kotecha RR; Reznik E
    Front Oncol; 2022; 12():910147. PubMed ID: 35837094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal Medullary Carcinoma: a Report of the Current Literature.
    Blas L; Roberti J; Petroni J; Reniero L; Cicora F
    Curr Urol Rep; 2019 Jan; 20(1):4. PubMed ID: 30656488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytology of metastatic renal medullary carcinoma in pleural effusion: a study of two cases.
    Ellis CL; Burroughs F; Michael CW; Li QK
    Diagn Cytopathol; 2009 Nov; 37(11):843-8. PubMed ID: 19526572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling.
    Pal SK; Choueiri TK; Wang K; Khaira D; Karam JA; Van Allen E; Palma NA; Stein MN; Johnson A; Squillace R; Elvin JA; Chmielecki J; Yelensky R; Yakirevich E; Lipson D; Lin DI; Miller VA; Stephens PJ; Ali SM; Ross JS
    Eur Urol; 2016 Sep; 70(3):516-21. PubMed ID: 26149668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.
    Ohe C; Smith SC; Sirohi D; Divatia M; de Peralta-Venturina M; Paner GP; Agaimy A; Amin MB; Argani P; Chen YB; Cheng L; Colecchia M; Compérat E; Werneck da Cunha I; Epstein JI; Gill AJ; Hes O; Hirsch MS; Jochum W; Kunju LP; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Nesi G; Osunkoya AO; Picken MM; Rao P; Reuter VE; de Oliveira Salles PG; Schultz L; Tickoo SK; Tomlins SA; Trpkov K; Amin MB
    Am J Surg Pathol; 2018 Mar; 42(3):279-292. PubMed ID: 29309300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.